 |
 |
|
|
RESÚMENES AGOSTO 2005 |
Psychotic Disorders & Antipsychotics
(Requiere estar conectado a internet. Haga un click en la
información del journal)
RICHARD WARNER
The British Journal of Psychiatry (2005) 187:
s104-s107
PATRICK D. McGORRY
The British Journal of Psychiatry (2005) 187:
s108-s110
Predictors of schizophrenia. Evidence from the Northern Finland 1966 Birth Cohort and other sources
MATTI ISOHANNI, ERIKA LAURONEN, KRISTIINA MOILANEN, IRENE ISOHANNI,
LIISA KEMPPAINEN, HANNU KOPONEN, JOUKO MIETTUNEN, PIRJO MÄKI, SAMI RÄSÄNEN,
JUHA VEIJOLA, PEKKA TIENARI, KARL-ERIK WAHLBERG, GRAHAM K. MURRAY
The British Journal of Psychiatry (2005) 187: s4-s7
MATCHERI S. KESHAVAN, GREGOR BERGER, ROBERT B. ZIPURSKY, STEPHEN J.
WOOD, CHRISTOS PANTELIS
The British Journal of Psychiatry (2005) 187: s8-s18
ROSS M.G. NORMAN, SHÔN W. LEWIS, MAX MARSHALL
The British Journal of Psychiatry (2005) 187: s19-s23
Prepsychotic phase of schizophrenia and related disorders: recent progress and future opportunities
LISA J. PHILLIPS, PATRICK D. McGORRY, ALISON R. YUNG, THOMAS H.
McGLASHAN, BARBARA CORNBLATT, JOACHIM KLOSTERKÖTTER
The British Journal of Psychiatry (2005) 187: s33-s44
PETER HANDEST, JOSEF PARNAS
The British Journal of Psychiatry (2005) 187: s49-s54
LONE PETERSEN, MERETE NORDENTOFT, PIA JEPPESEN, JOHAN ØHLENSCHLÆGER,
ANNE THORUP, TORBEN ØSTERGAARD CHRISTENSEN, GERTRUD KRARUP, JYTTE DAHLSTRØM,
BODIL HAASTRUP, PER JØRGENSEN
The British Journal of Psychiatry (2005) 187: s98-s103
Beng-Choon Ho, Daniel Alicata, Carmencita Mola, and Nancy C. Andreasen
Am J Psychiatry 162:1527-1529, August 2005
Six-Month, Blinded, Multicenter Continuation Study of Ziprasidone Versus Olanzapine in Schizophrenia
George M. Simpson, Peter Weiden, Theresa Pigott, Stephen Murray,
Cynthia O. Siu, and Steven J. Romano
Am J Psychiatry 162:1535-1538, August 2005
Chromatin
Alterations Associated With Down-regulated Metabolic Gene Expression in the
Prefrontal Cortex of Subjects With Schizophrenia
Schahram
Akbarian, Martin G. Ruehl, Erin Bliven, Lori A. Luiz, Amy C. Peranelli, Stephen
P. Baker, Rosalinda C. Roberts, William E. Bunney, Jr, Robert C. Conley, Edward
G. Jones, Carol A. Tamminga, Yin Guo
Arch Gen Psychiatry. 2005;62:829-840
Family History of Psychiatric Illness as a Risk Factor for
Schizoaffective Disorder. A Danish Register-Based Cohort Study
Thomas
Munk Laursen, Rodrigo Labouriau, Rasmus W. Licht, Aksel Bertelsen, Trine
Munk-Olsen, Preben Bo Mortensen
Arch Gen Psychiatry. 2005;62:841-848
Effect of switching antipsychotics on antiparkinsonian medication use in schizophrenia. Population-based study
SYLVIA PARK
The British Journal of Psychiatry (2005) 187: 137-142
Membrane
phospholipid composition, alterations in neurotransmitter systems and
schizophrenia
Teresa M. du Bois,
Chao Deng and Xu-Feng Huang
Hypothesis:
Minimal changes in neural transmission in schizophrenia: Decreased
glutamatergic and GABAergic functions in the prefrontal cortex
Tohru Ohnuma,
Toshihito Suzuki and Heii Arai
Safety and
effectiveness of olanzapine in monotherapy: A multivariate analysis of a
naturalistic study
Antonio Ciudad,
Miguel Gutiérrez, Fernando Cañas, Juan Gibert, Josep Gascón, José-Luis
Carrasco, Julio Bobes, Juan-Carlos Gómez and Enrique Alvarez
Clinical
pharmacogenetics in the treatment of schizophrenia
Saito M, Yasui-Furukori N,
Kaneko S
Nihon Shinkei Seishin Yakurigaku Zasshi. 2005
Jun;25(3):129-35
Serum
concentrations of haloperidol pyridinium metabolites and the relationship with
tardive dyskinesia and parkinsonism: a cross-section study in psychiatric
patients.
Ulrich S, Sandmann U, Genz
A
Pharmacopsychiatry. 2005 Jul;38(4):171-7
Aripiprazole: Initial Clinical Experience with 142 Hospitalized
Psychiatric Patients
CENTORRINO, FRANCA; FOGARTY, KATE V.;
CIMBOLLI, PAOLA; SALVATORE, PAOLA; THOMPSON, TERRI-ANN; SANI, GABRIELE;
CINCOTTA, STEPHANIE L.; BALDESSARINI, ROSS J
Journal of Psychiatric Practice. 11(4):241-247, July
2005
Prevalence
of obesity, glucose homeostasis disorders and metabolic syndrome in psychiatric
patients taking typical or atypical antipsychotic drugs: a cross-sectional
study
Mackin P, Watkinson HM, Young AH
Diabetologia. 2005 Feb;48(2):215-21. Epub 2005 Feb 2
Response and Relapse in Patients With Schizophrenia Treated With Olanzapine, Risperidone, Quetiapine, or Haloperidol: 12-Month Follow-Up of the Intercontinental Schizophrenia Outpatient Health Outcomes (IC-SOHO) Study
Martin Dossenbach,
Cesar Arango-Dávila, Hernan Silva Ibarra, Eric Landa, Jaime Aguilar, Osvaldo
Caro, Joanna Leadbetter, and Sheila Assunção
J Clin Psychiatry 2005;66:1021-1030
Melissa A.
Kalarchian, Marsha D. Marcus, Michele D. Levine, Gretchen L. Haas, Catherine G.
Greeno, Lisa A. Weissfeld, and Li Qin
J Clin Psychiatry 2005;66:1058-1063
Symptomatic Remission in Patients With Bipolar Mania: Results From a Double-Blind, Placebo-Controlled Trial of Risperidone Monotherapy
Srihari Gopal,
David C. Steffens, Michelle L. Kramer, and Maren K. Olsen
J Clin Psychiatry 2005;66:1016-1020
Topiramate Add-On in Treatment-Resistant Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled, Crossover Trial
Jari Tiihonen,
Pirjo Halonen, Kristian Wahlbeck, Eila Repo-Tiihonen, Soile Hyvärinen, Markku
Eronen, Hanna Putkonen, Pirjo Takala, Olli-Pekka Mehtonen, Martin Puck, Jorma
Oksanen, Pasi Koskelainen, Grigori Joffe, Juhani Aer, Tero Hallikainen,
Olli-Pekka Ryynänen, and Erkki Tupala
J Clin Psychiatry 2005;66:1012-1015
Matthew J. Byerly,
Robert Fisher, Thomas Carmody, and A. John Rush
J Clin Psychiatry 2005;66:997-1001
Improved Sleep Continuity and Increased Slow Wave Sleep and REM Latency During Ziprasidone Treatment: A Randomized, Controlled, Crossover Trial of 12 Healthy Male Subjects
Stefan Cohrs,
Andreas Meier, Anna-Catharina Neumann, Wolfgang Jordan, Eckart Rüther, and
Andrea Rodenbeck
J Clin Psychiatry 2005;66:989-996
An assessment of
emergent tardive dyskinesia and existing dyskinesia in patients receiving
long-acting, injectable risperidone: Results from a long-term study
Georges M.
Gharabawi, Cynthia A. Bossie, Young Zhu, Lian Mao and Robert A. Lasser
Schizophrenia
Research. Volume 77, Issues 2-3, 15 September 2005, Pages 129-139
Examining the
latent structure of negative symptoms: Is there a distinct subtype of negative
symptom schizophrenia?
Jack J. Blanchard,
William P. Horan and Lindsay M. Collins
Schizophrenia
Research. Volume 77, Issues 2-3, 15 September 2005, Pages 151-165
Patient
characteristics and the likelihood of initiation on olanzapine or risperidone
among patients with schizophrenia
Xinhua S. Ren,
Lewis E. Kazis, Austin F. Lee, Yu-Hui Huang, Alaa Hamed, Francesca Cunningham,
Lawrence Herz and Donald R. Miller
Schizophrenia
Research. Volume 77, Issues 2-3, 15 September 2005, Pages 167-177
Contrasting
loxapine to its isomer isoloxapine—the critical role of in vivo D2
blockade in determining atypicality
Sridhar Natesan,
Suzi VanderSpek, José N. Nobrega, Robert A. McClelland and Shitij Kapur
Schizophrenia
Research. Volume 77, Issues 2-3, 15 September 2005, Pages 189-199
Remission in
schizophrenia: Results from a 1-year study of long-acting risperidone injection
Robert A. Lasser,
Cynthia A. Bossie, Georges M. Gharabawi and John M. Kane
Schizophrenia
Research. Volume 77, Issues 2-3, 15 September 2005, Pages 215-227
Variations in
differential gene expression patterns across multiple brain regions in
schizophrenia
P. Katsel, K.L.
Davis, J.M. Gorman and V. Haroutunian
Schizophrenia
Research. Volume 77, Issues 2-3, 15 September 2005, Pages 241-252
Association
between the polymorphic GRM3 gene and negative symptom improvement during
olanzapine treatment
Jeffrey R. Bishop,
Vicki L. Ellingrod, Jessica Moline and Del Miller
Schizophrenia
Research. Volume 77, Issues 2-3, 15 September 2005, Pages 253-260
John S. Brekke, Eri
Nakagami, Kimmy S. Kee and Michael F. Green
Schizophrenia
Research. Volume 77, Issues 2-3, 15 September 2005, Pages 289-298
Atypical
antipsychotic medications and risk of falls in residents of aged care
facilities
Hien le TT, Cumming RG, Cameron ID, Chen JS, Lord SR, March LM, Schwarz J, Le
Couteur DG, Sambrook PN
J Am Geriatr Soc. 2005 Aug;53(8):1290-5
Antipsychotic drugs and QT prolongation
Stollberger, Claudia; Huber, Johannes O;
Finsterer, Josef
International Clinical Psychopharmacology.
20(5):243-251, September 2005
Functional imaging
evidence of the relationship between recurrent psychotic episodes and neurodegenerative
course in schizophrenia
Bum Seok Jeong, Jun
Soo Kwon, Seong Yoon Kim, Chul Lee, Tak Youn, Chan-Hong Moon and Chang Yoon Kim
Psychiatry Research: Neuroimaging. Volume 139, Issue
3, 30 August 2005, Pages 219-228
Risperidone,
Quetiapine, and Fluphenazine in the Treatment of Patients With
Therapy-Refractory Schizophrenia
Conley RR, Kelly DL, Nelson MW, Richardson CM, Feldman S, Benham R, Steiner P,
Yu Y, Khan I, McMullen R, Gale E, Mackowick M, Love RC
Clin Neuropharmacol. 2005 July/August;28(4):163-168
Ten year
longitudinal study of neuropsychological functioning subsequent to a first
episode of schizophrenia
Anne L. Hoff,
Christine Svetina, Gail Shields, John Stewart and Lynn E. DeLisi
Schizophrenia
Research. Volume 78, Issue 1, 1 October 2005, Pages 27-34
Frontal lobe alterations in schizophrenia. Neuroimaging and
neuropsychological findings
J. C. Sanz de
la Torre, M. Barrios and C. Junqué
European Archives of Psychiatry and Clinical 2005;
Volume 255, Number 4: 236 - 244
Risperidone plasma levels, clinical response and side–effects
M. Riedel,
M. J. Schwarz, M. Strassnig, I. Spellmann,
A. Müller–Arends, K. Weber, J. Zach, N. Müller and
H. J. Möller
European Archives of Psychiatry and Clinical
Neuroscience 2005; Volume 255, Number 4: 261 - 268
Schizophrenia
and suicide: systematic review of risk factors
Hawton K, Sutton L, Haw C,
Sinclair J, Deeks JJ
Br J Psychiatry. 2005 Jul;187:9-20
Cécile Henquet, Robin Murray, Don Linszen, Jim van Os
Schizophrenia Bulletin 2005 31(3):608-612
Sarah Tosato, Paola Dazzan, David Collier
Schizophrenia Bulletin 2005 31(3):613-617
Do Patients with Schizophrenia Ever Show Periods of Recovery? A 15-Year Multi-Follow-up Study
Martin Harrow, Linda S Grossman, Thomas H Jobe, Ellen S Herbener
Schizophrenia Bulletin 2005 31(3):723-734
Predicting Recovery From Schizophrenia: A Retrospective Comparison of Characteristics at Onset of People With Single and Multiple Episodes
Kate Rosen, Philippa Garety
Schizophrenia Bulletin 2005 31(3):735-750
Structural Brain Imaging Evidence for Multiple Pathological Processes at Different Stages of Brain Development in Schizophrenia
Christos Pantelis, Murat Yücel, Stephen J Wood, Dennis Velakoulis,
Daqiang Sun, Gregor Berger, Geoff W Stuart, Alison Yung, Lisa Phillips, Patrick
D McGorry
Schizophrenia Bulletin 2005 31(3):672-696
Christian Fleischhaker, Eberhard Schulz, Kathrin Tepper, Matthias
Martin, Klaus Hennighausen, Helmut Remschmidt